Dr. Tim Guilliams
Co-founder and Chief Executive, Healx Ltd and Founding Director of CRDN
Facilitator for Moderated Panel Discussion: Disruptive technologies – Patients at the heart of AI
Bio: Tim is a tech entrepreneur from the Cambridge Cluster (UK). He is passionate about the application of artificial intelligence for drug discovery. He is the co-founder and Chief Executive of Healx Ltd, a tech company focused on accelerating treatments for rare diseases. Passionate about patient impact, he is also the Founding Director of the Cambridge Rare Disease Network. He obtained his PhD from Cambridge University in Biophysical Neuroscience and his MEng in Biochemical-Engineering from Brussels University.